Delivery Order SPE2DB20D3101-SPE2DB25FRWN9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Celebrex 200 mg capsules in unit dose packaging (100 count) with a contract value of $6,610.43. This is a firm fixed price delivery order with an ultimate completion date of September 8, 2025, and represents a non-competitive set-aside contract. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Celebrex 200 mg capsules (100 count) with a contract value of $2,387.86. This firm fixed-price delivery order, which will be completed by August 14, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Celebrex 200 mg capsules (100-count units) with a ceiling value of $3,786.34. This competitive award employs firm fixed pricing under a delivery order contract type with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location....
- On August 13, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,526.68 to AmerisourceBergen Drug Corp for 100 capsules of Celebrex 200 mg. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This delivery order, awarded on July 28, 2025, to AmerisourceBergen Drug Corp provides for the supply of Celebrex 200 mg capsules (100 count) with a ceiling value of $2,995.19 under a firm fixed price arrangement. The contract is not set aside and was competitively awarded by the Medical Supply Chain, a component of the Defense Logistics Agency. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for...
- The Defense Logistics Agency awarded a $1,507.44 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Celecoxib 200 mg capsules in quantities of 500 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 11, 2025. The award was issued from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters. This delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,597.57 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, for the supply of Celebrex 200 mg capsules (100 count). This is a firm fixed-price, non-set-aside competitive contract with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 29, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,503.49 for 500 capsules of Celecoxib 200 mg, a nonsteroidal anti-inflammatory medication. This non-set-aside, firm fixed price delivery order was awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a typical transactional purchase under the company's...
- The Defense Logistics Agency awarded a $1,512.46 delivery order to AmerisourceBergen Drug Corp for 500 capsules of Celecoxib 100 mg, a nonsteroidal anti-inflammatory medication. This firm fixed-price contract, with an ultimate completion date of July 1, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The award was competitively awarded without...
- The Defense Logistics Agency awarded a delivery order valued at $8,449.02 to AmerisourceBergen Drug Corp for 100 capsules of Celecoxib 200 mg, a nonsteroidal anti-inflammatory medication. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by September 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRWN9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Celebrex 200 mg capsules in unit dose packaging (100 count) with a ceiling value of $3,349.86. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set to be completed by September 26, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive global pharmaceutical support vehicle extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support Defense Health Agency operations and other government healthcare systems worldwide. This specific delivery order for Celebrex, a nonsteroidal anti-inflammatory medication commonly used in military healthcare settings, exemplifies the routine pharmaceutical procurement conducted under the broader vendor agreement that positions AmerisourceBergen to serve as one of several anticipated prime vendors under DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 9/25/25 |